2021 Impact Factor: 1.217
2021 CiteScore: 1.8
pISSN: 1735-7020
eISSN: 2008-238x
Editor-in-Chief:
Gholamhossein Edrissian, Pharm. D.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
Vol 18 No 1 (2023) | Manuscript count: 20 Article | xml |
Vol 17 No 4 (2022) | Manuscript count: 17 Article | xml |
Vol 17 No 3 (2022) | Manuscript count: 21 Article | xml |
Vol 17 No 2 (2022) | Manuscript count: 18 Article | xml |
Vol 17 No 1 (2022) | Manuscript count: 16 Article | xml |
Vol 16 No 4 (2021) | Manuscript count: 23 Article | xml |
Vol 16 No 3 (2021) | Manuscript count: 22 Article | xml |
Vol 16 No 2 (2021) | Manuscript count: 22 Article | xml |
Vol 16 No 1 (2021) | Manuscript count: 19 Article | xml |
Vol 15 No 4 (2020) | Manuscript count: 20 Article | xml |
Vol 15 No 3 (2020) | Manuscript count: 23 Article | xml |
Vol 15 No 2 (2020) | Manuscript count: 18 Article | xml |
Vol 15 No 1 (2020) | Manuscript count: 21 Article | xml |
Vol 14 No 4 (2019) | Manuscript count: 23 Article | xml |
Vol 14 No 3 (2019) | Manuscript count: 21 Article | xml |
Vol 14 No 2 (2019) | Manuscript count: 23 Article | xml |
Vol 14 No 1 (2019) | Manuscript count: 25 Article | xml |
Vol 13 No 4 (2018) | Manuscript count: 25 Article | xml |
Vol 13 No 3 (2018) | Manuscript count: 25 Article | xml |
Vol 13 No 2 (2018) | Manuscript count: 21 Article | xml |
Vol 13 No 1 (2018) | Manuscript count: 20 Article | xml |
Vol 12 No 4 (2017) | Manuscript count: 20 Article | xml |
Supplementary Issue | Manuscript count: 1 Article | xml |
Proceedings of “PARACON 2017”, Lahore, Pakistan: 25-26 Oct, 2017
Vol 12 No 3 (2017) | Manuscript count: 20 Article | xml |
Vol 12 No 2 (2017) | Manuscript count: 20 Article | xml |
2021 Impact Factor: 1.217
2021 CiteScore: 1.8
pISSN: 1735-7020
eISSN: 2008-238x
Editor-in-Chief:
Gholamhossein Edrissian, Pharm. D.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
![]() |
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |